CNV_2017_01 STERLING

  • Research type

    Research Study

  • Full title

    A Prospective, Multi-Center, Single Arm Study to obtain “real world” clinical data and characterize the acute and long term performance of the MICRUSFRAME and GALAXY coils including the PulseRider Aneurysm Neck Reconstruction Device for the endovascular treatment of intracranial aneurysms.

  • IRAS ID

    287747

  • Contact name

    Eugenia Mc Allister

  • Contact email

    MEugeni1@its.jnj.com

  • Sponsor organisation

    Cerenovus

  • Clinicaltrials.gov Identifier

    NCT03642639

  • Duration of Study in the UK

    3 years, 7 months, 1 days

  • Research summary

    The study is a post-market registry.The objective of this study is to obtain “real world” clinical data and characterize the acute and long-term performance of the MICRUSFRAME and GALAXY coils for the endovascular treatment of intracranial aneurysms.
    The secondary objective of this study is to evaluate “real world” outcomes with the use of the PulseRider Aneurysm Neck Reconstruction device for the endovascular treatment of intracranial aneurysms.
    The patient with ruptured and unruptured aneurisms that meet inclusion/exclusion criteria are eligible for the study.
    All the procedures of the study must be a standard of care at the selected sites.
    The study duration is expected to be approximately 6 years (including enrollment phase). The enrollment phase is expected to take approximately 5 years following enrollment of the first subject.
    It will take each participant approximately 1 year to complete the protocol required follow-up visits.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    21/YH/0166

  • Date of REC Opinion

    5 Aug 2021

  • REC opinion

    Unfavourable Opinion